[{"address1": "500 West 5th Street", "address2": "Suite 1200", "city": "Austin", "state": "TX", "zip": "78701", "country": "United States", "phone": "512 900 4690", "website": "https://www.shattucklabs.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.", "fullTimeEmployees": 75, "auditRisk": 6, "boardRisk": 6, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1717200000, "maxAge": 86400, "priceHint": 4, "previousClose": 4.165, "open": 4.18, "dayLow": 4.16, "dayHigh": 4.44, "regularMarketPreviousClose": 4.165, "regularMarketOpen": 4.18, "regularMarketDayLow": 4.16, "regularMarketDayHigh": 4.44, "beta": 1.861, "forwardPE": -2.6484847, "volume": 460395, "regularMarketVolume": 460395, "averageVolume": 318422, "averageVolume10days": 414040, "averageDailyVolume10Day": 414040, "bid": 4.31, "ask": 4.38, "bidSize": 100, "askSize": 200, "marketCap": 207797424, "fiftyTwoWeekLow": 1.33, "fiftyTwoWeekHigh": 11.76, "priceToSalesTrailing12Months": 76.536804, "fiftyDayAverage": 8.415, "twoHundredDayAverage": 6.28521, "currency": "USD", "enterpriseValue": 97178312, "floatShares": 31888090, "sharesOutstanding": 47550900, "sharesShort": 1583371, "sharesShortPriorMonth": 1797371, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.033299997, "heldPercentInsiders": 0.13332, "heldPercentInstitutions": 0.64115995, "shortRatio": 4.19, "shortPercentOfFloat": 0.050100002, "impliedSharesOutstanding": 47550900, "bookValue": 2.711, "priceToBook": 1.6119512, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -85078000, "trailingEps": -1.93, "forwardEps": -1.65, "enterpriseToRevenue": 35.793, "enterpriseToEbitda": -1.129, "52WeekChange": 0.4813559, "SandP52WeekChange": 0.26238096, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "STTK", "underlyingSymbol": "STTK", "shortName": "Shattuck Labs, Inc.", "longName": "Shattuck Labs, Inc.", "firstTradeDateEpochUtc": 1602250200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "64a83d67-d0cd-3885-8206-d0f94edae33a", "messageBoardId": "finmb_378179277", "gmtOffSetMilliseconds": -14400000, "currentPrice": 4.37, "targetHighPrice": 16.0, "targetLowPrice": 8.0, "targetMeanPrice": 11.0, "targetMedianPrice": 9.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 114633000, "totalCashPerShare": 2.411, "ebitda": -86038000, "totalDebt": 4014000, "quickRatio": 8.0, "currentRatio": 9.148, "totalRevenue": 2715000, "debtToEquity": 3.116, "revenuePerShare": 0.061, "returnOnAssets": -0.34736001, "returnOnEquity": -0.59398, "freeCashflow": -41475000, "operatingCashflow": -70928000, "revenueGrowth": 18.561, "operatingMargins": -17.976679, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]